Agios Pharmaceuticals, Inc.
AGIO
$34.41
-$1.09-3.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 665.99M | 673.73M | 674.31M | -364.93M | -352.62M |
| Total Depreciation and Amortization | 5.58M | 5.65M | 5.69M | 5.97M | 6.18M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.05B | -1.05B | -1.04B | 68.34M | 67.96M |
| Change in Net Operating Assets | -27.29M | -19.77M | 32.09M | -15.96M | -22.27M |
| Cash from Operations | -401.46M | -389.84M | -329.16M | -306.59M | -300.75M |
| Capital Expenditure | -2.31M | -1.69M | -952.00K | -902.00K | -741.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 40.00K | 40.00K | 1.22M | 1.22M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 200.00M | 200.00M | 200.00M | -- | -- |
| Other Investing Activities | 153.78M | 165.09M | 309.02M | 296.35M | 306.07M |
| Cash from Investing | 351.47M | 363.44M | 508.11M | 296.66M | 306.54M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10.20M | 14.44M | 10.45M | 9.69M | 8.83M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.20M | 14.44M | 10.45M | 9.69M | 8.83M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -39.80M | -11.96M | 189.40M | -235.00K | 14.63M |